ESC 365 - Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

ESC Premium Access

Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Session: Progress in anticoagulation for venous thromboembolism

Topic: Pulmonary Embolism (PE)

Speaker: Professor E. Klok (Leiden, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Erik Klok

Leiden University Medical Center, Leiden (Netherlands (The))

8 presentations

3 followers

3 more presentations in this session

State of the Art - Optimizing the prevention of venous thromboembolism

Speaker: Professor A. Spyropoulos (New York, US)

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Speaker: Doctor Y. Yamashita (Kyoto, JP)

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)

Access the full session

Progress in anticoagulation for venous thromboembolism

Speakers: Professor E. Klok, Professor A. Spyropoulos, Doctor Y. Yamashita, Doctor A. Kalayci Karabay

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources